|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/06 | |||
| A61K 47/14 | |||
| A61K 9/06 | |||
| A61K 31/5575 |
| (11) | Patento numeris | 3124015 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16177742.0 |
| Europos patento paraiškos padavimo data | 2014-05-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-03-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361822139 P | 2013-05-10 | US |
| (72) |
SINGER, Michael, S., US
KALAYOGLU, Murat, V., US
|
| (73) |
Topokine Therapeutics, Inc.,
241 Nahanton Street, Newton, MA 02459,
US
|
| (54) | COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT |
| COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT |